Overview

Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

Status:
Unknown status
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Vascana, a novel topical formulation of nitroglycerin, is effective in the treatment and prevention of the symptoms associated with Raynaud's Phenomenon.
Phase:
Phase 3
Details
Lead Sponsor:
MediQuest Therapeutics
Treatments:
Nitroglycerin